Duke University Health System shared a post on LinkedIn about a recent article by Abbie S. Ireland et al, published in Nature:
“Inside the Lab: Duke’s Breakthrough in Lung Cancer Research.
Duke researchers have discovered that small cell lung cancer likely begins in basal stem cells – not neuroendocrine cells. This could change how we understand, detect, and treat one of the deadliest cancers.
Watch as we take you inside the lab to hear directly from the scientists and see how they made this discovery.
Co-led by Trudy Oliver, Ph.D., and graduate student Abbie Ireland, the study is now published in Nature.
Learn more.”
Proceed to the video attached to the post.
Title: Basal cell of origin resolves neuroendocrine–tuft lineage plasticity in cancer
Authors: Abbie S. Ireland, Daniel A. Xie, Sarah B. Hawgood, Margaret W. Barbier, Lisa Y. Zuo, Benjamin E. Hanna, Scarlett Lucas-Randolph, Darren R. Tyson, Benjamin L. Witt, Ramaswamy Govindan, Afshin Dowlati, Justin C. Moser, Anish Thomas, Sonam Puri, Charles M. Rudin, Joseph M. Chan, Andrew Elliott, Trudy G. Oliver
Read the Full Article on Nature
James Hamrick, Chair of Precision Oncology Alliance at Caris Life Sciences, shared a Duke University Health System’s post on LinkedIn, adding:
“A recent study led by Duke University Health System, which utilized Caris Life Sciences data to validate, lays the foundation for understanding the biology behind aggressive cancers like small cell lung cancer. By identifying the cell of origin, researchers are unlocking new possibilities for treatment.
This is a powerful example of how the Caris Precision Oncology Alliance enables cross-institutional collaboration to drive meaningful progress in oncology.”
More posts featuring Lung Cancer.